Dermal pharmacokinetics of the insecticide furathiocarb in rats.
Kwang-Hyeon Liu, Ha-Jung Sung, Hae-Keun Lee, Byung-Hun Song, Yang-Bin Ihm, Kyun Kim, Hye-Suk Lee, Jeong-Han Kim
Index: Pest Manag. Sci. 58(1) , 57-62, (2002)
Full Text: HTML
Abstract
The pharmacokinetics of furathiocarb were studied in vivo in male Sprague-Dawley rats following dermal treatment. HPLC and post-column derivatization were used for the analysis of furathiocarb and its metabolites (carbofuran, 3-hydroxycarbofuran and 3-ketocarbofuran). Carbofuran and 3-hydroxycarbofuran were detected in plasma and urine rather than furathiocarb. 3-Ketocarbofuran, another potential metabolite, was not observed in any sample. The concentration of carbofuran was higher than that of 3-hydroxycarbofuran in plasma, but the reverse was the case in urine. The corresponding area under the plasma concentration-time curve, Tmax, and Cmax values of carbofuran and 3-hydroxycarbofuran for 1500 mg kg-1 doses were 2.4-8.0 mg equiv hml-1, 12 h and 0.1-0.4 mg equiv ml-1, respectively. T1/2 was calculated only for 3-hydroxycarbofuran (28 h). Two metabolites were excreted in a dose-dependent manner without saturation.
Related Compounds
Related Articles:
2006-01-01
[J. AOAC Int. 89(1) , 214-24, (2006)]
1998-05-01
[J. Environ. Sci. Health B 33(3) , 253-66, (1998)]
2011-10-10
[Forensic Sci. Int. 212(1-3) , e10-4, (2011)]
1983-01-01
[J. Environ. Sci. Health B 18(2) , 301-4, (1983)]
1982-07-01
[Gig. Sanit. (7) , 45-6, (1982)]